XML 56 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Collaboration Agreements - Summary of Revenue Recognized under Agreement (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue $ 24,401 $ 23,863
License Revenue [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 0 0
Development Revenue [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 19,446 23,863
Astellas Agreement [Member] | License Revenue [Member] | Japan [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 0 0
Astellas Agreement [Member] | License Revenue [Member] | Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 0 0
Astellas Agreement [Member] | Development Revenue [Member] | Japan [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 163 246
Astellas Agreement [Member] | Development Revenue [Member] | Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 4,574 4,613
AstraZeneca Agreements [Member] | China [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 153 0
AstraZeneca Agreements [Member] | License Revenue [Member] | U.S./RoW and China [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue 0 0
AstraZeneca Agreements [Member] | Development Revenue [Member] | U.S./RoW and China [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Total revenue $ 14,556 $ 19,004